Haematologica (Sep 2008)

Epstein-Barr virus reactivation is a potentially severe complication in chronic lymphocytic leukemia patients with poor prognostic biological markers and fludarabine refractory disease

  • Julie Rath,
  • Christian Geisler,
  • Claus B. Christiansen,
  • Nina Hastrup,
  • Hans O. Madsen,
  • Mette K. Andersen,
  • Lone B. Pedersen,
  • Jesper Jurlander

DOI
https://doi.org/10.3324/haematol.13059
Journal volume & issue
Vol. 93, no. 9

Abstract

Read online

No abstracts available.